Financhill
Buy
85

EHC Quote, Financials, Valuation and Earnings

Last price:
$117.64
Seasonality move :
16.76%
Day range:
$115.51 - $118.21
52-week range:
$82.74 - $118.27
Dividend yield:
0.56%
P/E ratio:
24.30x
P/S ratio:
2.18x
P/B ratio:
5.49x
Volume:
604.8K
Avg. volume:
1M
1-year change:
36.47%
Market cap:
$11.9B
Revenue:
$5.4B
EPS (TTM):
$4.84

Analysts' Opinion

  • Consensus Rating
    Encompass Health has received a consensus rating of Buy. The company's average rating is a Buy based on 10 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $130.09, Encompass Health has an estimated upside of 10.61% from its current price of $117.61.
  • Price Target Downside
    According to analysts, the lowest downside price target is $122.00 representing 100% downside risk from its current price of $117.61.

Fair Value

  • According to the consensus of 10 analysts, Encompass Health has 10.61% upside to fair value with a price target of $130.09 per share.

EHC vs. S&P 500

  • Over the past 5 trading days, Encompass Health has underperformed the S&P 500 by -3.3% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Encompass Health does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Encompass Health has grown year-over-year revenues for 11 quarters straight. In the most recent quarter Encompass Health reported revenues of $1.5B.

Earnings Growth

  • Encompass Health has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Encompass Health reported earnings per share of $1.48.
Enterprise value:
15B
EV / Invested capital:
2.77x
Price / LTM sales:
2.18x
EV / EBIT:
15.90x
EV / Revenue:
2.72x
PEG ratio (5yr expected):
0.79x
EV / Free cash flow:
38.84x
Price / Operating cash flow:
31.08x
Enterprise value / EBITDA:
11.99x
Gross Profit (TTM):
$2.3B
Return On Assets:
7.67%
Net Income Margin (TTM):
8.97%
Return On Equity:
18.4%
Return On Invested Capital:
9.36%
Operating Margin:
18.35%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $4.4B $5B $5.5B $1.3B $1.5B
Gross Profit $1.8B $2.1B $2.3B $545.9M $630.9M
Operating Income $656.2M $760.7M $924M $207.5M $267M
EBITDA $909.3M $1.1B $1.3B $283.9M $349.6M
Diluted EPS $2.70 $3.70 $4.84 $1.10 $1.48
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $1B $949.7M $761.7M $929.8M $910.9M
Total Assets $6.5B $6.9B $5.7B $6.2B $6.6B
Current Liabilities $812.2M $754.5M $592.1M $680.3M $856M
Total Liabilities $4.5B $4.5B $3.8B $3.8B $3.7B
Total Equity $2.1B $2.5B $2B $2.4B $2.9B
Total Debt $3.3B $3.3B $2.7B $2.7B $2.5B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations $714.8M $861.7M $1.1B $238.8M $288.6M
Cash From Investing -$607.9M -$628.5M -$682.1M -$129.7M -$158.5M
Cash From Financing -$142.8M -$179.8M -$420.4M -$40.6M -$130.4M
Free Cash Flow $143.8M $239M $386.4M $99.4M $125.5M
EHC
Sector
Market Cap
$11.9B
$34.7M
Price % of 52-Week High
99.45%
44.12%
Dividend Yield
0.56%
0%
Shareholder Yield
1.72%
-0.67%
1-Year Price Total Return
36.47%
-40.33%
Beta (5-Year)
0.930
0.660
Dividend yield:
0.56%
Annualized payout:
$0.47
Payout ratio:
13.12%
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $116.79
200-day SMA
Buy
Level $97.85
Bollinger Bands (100)
Buy
Level 93.28 - 107.22
Chaikin Money Flow
Buy
Level 216.7M
20-day SMA
Buy
Level $110.89
Relative Strength Index (RSI14)
Buy
Level 69.35
ADX Line
Buy
Level 26.17
Williams %R
Sell
Level -3.7916
50-day SMA
Buy
Level $103.98
MACD (12, 26)
Buy
Level 4.29
25-day Aroon Oscillator
Buy
Level 48
On Balance Volume
Neutral
Level 163.3M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.9644)
Sell
CA Score (Annual)
Level (-0.4445)
Buy
Beneish M-Score (Annual)
Level (-2.7488)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.4636)
Buy
Piotroski F Score (Annual)
Level (8)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.

Stock Forecast FAQ

In the current month, EHC has received 10 Buy ratings 0 Hold ratings, and 0 Sell ratings. The EHC average analyst price target in the past 3 months is $130.09.

  • Where Will Encompass Health Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Encompass Health share price will rise to $130.09 per share over the next 12 months.

  • What Do Analysts Say About Encompass Health?

    Analysts are divided on their view about Encompass Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Encompass Health is a Sell and believe this share price will drop from its current level to $122.00.

  • What Is Encompass Health's Price Target?

    The price target for Encompass Health over the next 1-year time period is forecast to be $130.09 according to 10 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is EHC A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Encompass Health is a Buy. 10 of 10 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of EHC?

    You can purchase shares of Encompass Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Encompass Health shares.

  • What Is The Encompass Health Share Price Today?

    Encompass Health was last trading at $117.64 per share. This represents the most recent stock quote for Encompass Health. Yesterday, Encompass Health closed at $117.61 per share.

  • How To Buy Encompass Health Stock Online?

    In order to purchase Encompass Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Which Stocks Are Recession-Proof?
Which Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Is Gartner a Safe Stock to Own?
Is Gartner a Safe Stock to Own?

Gartner (NYSE:IT) is among the world’s largest consulting, research and…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 44x

Alerts

Buy
57
RGC alert for May 14

Regencell Bioscience Holdings [RGC] is down 31.81% over the past day.

Buy
54
HALO alert for May 14

Halozyme Therapeutics [HALO] is down 24.57% over the past day.

Buy
91
COIN alert for May 14

Coinbase Global [COIN] is up 24.64% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock